Drawing for ALLPLEX

USPTO serial 79178454

ALLPLEX

Reviewed by CopyMark Law Group

Reg. 5066446Status 706Renewal
Filing date
Status date
Registration date
Oct 25, 2016
Examiner
CHERY, JEFFREY
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with ALLPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith Birch Stewart Kolasch & Birch, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for clinical purposes; diagnostic reagents for medical laboratory use; diagnostic reagents for medical use; [ diagnostic reagents for veterinary use; chemical reagents for medical purposes; ] chemical reagents for veterinary purposes; [ medical diagnostic reagents for the diagnosis of genetic diseases; medical diagnostic reagents for the diagnosis of cancer; ] medical diagnostic reagent for diagnosis of the infection of microorganism; medical diagnostic reagent for diagnosis of the infection of viruses; medical diagnostic reagent for diagnosis of contagious infections; diagnostic preparations for medical purposes; diagnostic test kits comprising diagnostic reagents for in vitro testing for medical purposes; [ diagnostic test kits comprising diagnostic reagents for in vitro testing for veterinary purposes; diagnostic test kits comprising medical diagnostic reagents for in vitro testing for the diagnosis of genetic diseases; diagnostic test kits comprising medical diagnostic reagents for in vitro testing for the diagnosis of cancer; ] diagnostic kits comprising medical diagnostic reagents for in vitro testing for the detection of infections of microorganisms; diagnostic test kits comprising medical diagnostic reagents for in vitro testing for the detection of infections of viruses; diagnostic kits comprising medical diagnostic reagents for in vitro testing for the detection of contagious infectionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 26, 202671AGREGISTERED-SEC.71 ACCEPTED—
Sep 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 5, 2026ES71TEAS SECTION 71 RECEIVED—
Oct 26, 2025REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Mar 13, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 13, 2023NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 13, 2023C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Feb 13, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 9, 2022ES75TEAS SECTION 71 & 15 RECEIVED—
Oct 25, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 12, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 1, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 1, 2017FIMPFINAL DISPOSITION PROCESSED—
Jan 25, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 25, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 9, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 9, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 20, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 20, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 1, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 1, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 1, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 1, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 23, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2016RFNPREFUSAL PROCESSED BY IB—
Jan 5, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 5, 2016RFRRREFUSAL PROCESSED BY MPU—
Dec 29, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 23, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 22, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2015DOCKASSIGNED TO EXAMINER—
Dec 21, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance